Before joining Mantell Associates Maria worked within the regulatory affairs space, from clinical to post approval within various organisations, from start-ups to Big Pharma. She has extensive experience within all modalities in new drug development, cell and gene therapy, small molecule, CMC, strategy, policy intelligence and more.
In 2023, Maria made the move across to Mantell Associates to aid our US growth, and will be focusing primarily on research and development for new drug development focused biotech and pharmaceutical organisations.